Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal dominant non-syndromic intellectual disability in which the cause of the disease is a mutation in the CHAMP1 gene.
Features include always present findings: Tented upper lip vermilion, Hypermetropia, Low muscle tone (hypotonia), and Motor delay and others; and very common findings: Thin upper lip vermilion, Impaired pain sensation, Facial hypotonia, and Feeding difficulties and others. 40 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 7 | Tented upper lip vermilion, Thin upper lip vermilion, High palate |
Brain and nerves | 7 | Gait ataxia, Brain atrophy, Intellectual disability |
Muscles | 3 | Low muscle tone (hypotonia), Brain atrophy, Facial hypotonia |
Digestive system | 2 | Gastroesophageal reflux, Feeding difficulties |
Lungs and breathing | 2 | Obstructive sleep apnea, Recurrent respiratory infections |
Eyes | 1 | Strabismus |
Bones and joints | 1 | Joint hypermobility |
Blood and immune system | 1 | Recurrent respiratory infections |
Age of onset: newborn period.
CHAMP1 encodes chromosome alignment maintaining phosphoprotein 1 (812 aa). Required for proper alignment of chromosomes at metaphase and their accurate segregation during mitosis. Highest expression in Cells Cultured fibroblasts (41.1 TPM) and Cells EBV-transformed lymphocytes (39.2 TPM).
Intellectual disability, autosomal dominant 40 is associated with mutations in the CHAMP1 gene on chromosome 13.
CHAMP1 is classified as a druggable target with score 0.0.
Genetic testing for CHAMP1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for intellectual disability, autosomal dominant 40 has been reported in the published literature.
Phenotype severity distribution: 12 always present features, 6 very common features, 19 common features.
No clinical trials have been registered for intellectual disability, autosomal dominant 40.
13 publications have been identified in PubMed for intellectual disability, autosomal dominant 40. Research spans Case Report / Case Series (31%), Review / Meta-Analysis (23%), and Basic Science / Preclinical (23%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 31% |
Research summaries | 3 | 23% |
Laboratory research | 3 | 23% |
Testing and diagnosis research | 1 | 8% |
Clinical study results | 1 | 8% |
Disease patterns and progression | 1 | 8% |
da Costa Urbano JC (2026). [PMID: 42050746](https://pubmed.ncbi.nlm.nih.gov/42050746/). *Am J Med Genet A*. [Case Report / Case Series]
Cipri S (2026). [PMID: 41700448](https://pubmed.ncbi.nlm.nih.gov/41700448/). *American journal of medical genetics. Part A*. [Diagnostic / Biomarker]
van der Leij M (2026). [PMID: 41680088](https://pubmed.ncbi.nlm.nih.gov/41680088/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Guo W (2026). [PMID: 41810193](https://pubmed.ncbi.nlm.nih.gov/41810193/). *Translational pediatrics*. [Basic Science / Preclinical]
Russell JK (2026). [PMID: 41709686](https://pubmed.ncbi.nlm.nih.gov/41709686/). *Current opinion in neurology*. [Review / Meta-Analysis]
Celik VD (2026). [PMID: 41940405](https://pubmed.ncbi.nlm.nih.gov/41940405/). *Mol Syndromol*. [Clinical Trial Publication]
Videla L (2025). [PMID: 40528282](https://pubmed.ncbi.nlm.nih.gov/40528282/). *Alzheimer's & dementia : the journal of the Alzheimer's Association*. [Review / Meta-Analysis]
Rafii MS (2025). [PMID: 40818475](https://pubmed.ncbi.nlm.nih.gov/40818475/). *The Lancet. Neurology*. [Review / Meta-Analysis]
Moses RG (2025). [PMID: 40519070](https://pubmed.ncbi.nlm.nih.gov/40519070/). *American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics*. [Basic Science / Preclinical]
Roberts JP (2025). [PMID: 40061310](https://pubmed.ncbi.nlm.nih.gov/40061310/). *medRxiv : the preprint server for health sciences*. [Epidemiology / Natural History]
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 4:17 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center